UBIO

Proshares UltraPro NASDAQ Biotechnology
UBIO

Delisted

UBIO was delisted on the 27th of March, 2020.

Back to rankings

8 hedge funds and large institutions have $2.16M invested in Proshares UltraPro NASDAQ Biotechnology in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

99% less call options, than puts

Call options by funds: $2K | Put options by funds: $384K

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2K
Puts
$384K
Net Calls
Net Calls Change

Top Buyers

1
+$53.9K
2
+$44K

Top Sellers

1
-$1.77M
2
-$790K
3
-$600K
4
TRCT
Tower Research Capital (TRC)
New York
-$64.4K
5
Morgan Stanley
Morgan Stanley
New York
-$4.47K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$961K
2
$610K
3
$318K
4
$144K
5
$44K
6
$36K
7
$32K
8
$12.2K
9
–
10
–